Mitochondrial function and morphology are impaired in parkin‐mutant fibroblasts
- 1 November 2008
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 64 (5), 555-565
- https://doi.org/10.1002/ana.21492
Abstract
Objective There are marked mitochondrial abnormalities in parkin‐knock‐out Drosophila and other model systems. The aim of our study was to determine mitochondrial function and morphology in parkin‐mutant patients. We also investigated whether pharmacological rescue of impaired mitochondrial function may be possible in parkin‐mutant human tissue. Methods We used three sets of techniques, namely, biochemical measurements of mitochondrial function, quantitative morphology, and live cell imaging of functional connectivity to assess the mitochondrial respiratory chain, the outer shape and connectivity of the mitochondria, and their functional inner connectivity in fibroblasts from patients with homozygous or compound heterozygous parkin mutations. Results Parkin‐mutant cells had lower mitochondrial complex I activity and complex I–linked adenosine triphosphate production, which correlated with a greater degree of mitochondrial branching, suggesting that the functional and morphological effects of parkin are related. Knockdown of parkin in control fibroblasts confirmed that parkin deficiency is sufficient to explain these mitochondrial effects. In contrast, 50% knockdown of parkin, mimicking haploinsufficiency in human patient tissue, did not result in impaired mitochondrial function or morphology. Fluorescence recovery after photobleaching assays demonstrated a lower level of functional connectivity of the mitochondrial matrix, which further worsened after rotenone exposure. Treatment with experimental neuroprotective compounds resulted in a rescue of the mitochondrial membrane potential. Interpretation Our study demonstrates marked abnormalities of mitochondrial function and morphology in parkin‐mutant patients and provides proof‐of‐principle data for the potential usefulness of this new model system as a tool to screen for disease‐modifying compounds in genetically homogenous parkinsonian disorders. Ann Neurol 2008;64:555–565Keywords
This publication has 35 references indexed in Scilit:
- Complex I deficiency in Parkinson's disease frontal cortexBrain Research, 2007
- Parkinson's diseaseHuman Molecular Genetics, 2007
- The mitochondrial E3 ubiquitin ligase MARCH5 is required for Drp1 dependent mitochondrial divisionThe Journal of cell biology, 2007
- Parkingene variations and parkinsonism: Association does not imply causationAnnals of Neurology, 2007
- Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by ParkinProceedings of the National Academy of Sciences, 2006
- Simultaneous quantitative measurement and automated analysis of mitochondrial morphology, mass, potential, and motility in living human skin fibroblastsCytometry Part A, 2005
- Mitochondrial network complexity and pathological decrease in complex I activity are tightly correlated in isolated human complex I deficiencyAmerican Journal of Physiology-Cell Physiology, 2005
- Respiration and Growth Defects in Transmitochondrial Cell Lines Carrying the 11778 Mutation Associated with Leber's Hereditary Optic NeuropathyJournal of Biological Chemistry, 1996
- An Evaluation of the Measurement of the Activities of Complexes I-IV in the Respiratory Chain of Human Skeletal Muscle MitochondriaBiochemical Medicine and Metabolic Biology, 1994
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976